1. Chen, Lixin, Qian, Ji, You, Qinghua, Ma, Jie. . LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway. In Bioengineered, 12, 10089-10100. doi:10.1080/21655979.2021.2000732. https://pubmed.ncbi.nlm.nih.gov/34724866/
2. Zhong, Qi-Yu, Xie, Ying-Wei, Chen, Zhi-Liang, Xie, Wen-Lian, Yan, Wei. 2022. LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma. In Neoplasma, 69, 832-840. doi:10.4149/neo_2022_211130N1701. https://pubmed.ncbi.nlm.nih.gov/35532296/
3. Tao, Ping, Chen, Xiaoming, Xu, Lei, Xu, Mujuan, Feng, Jianyi. . LIMD2 is the Signature of Cell Aging-immune/Inflammation in Acute Myocardial Infarction. In Current medicinal chemistry, 31, 2400-2413. doi:10.2174/0109298673274563231031044134. https://pubmed.ncbi.nlm.nih.gov/37936458/
4. Araldi, Rodrigo Pinheiro, de Melo, Thatiana Correa, Levy, Débora, Rauscher, Frank J, Cerutti, Janete Maria. 2020. LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk. In Cells, 9, . doi:10.3390/cells9112522. https://pubmed.ncbi.nlm.nih.gov/33238381/
5. Zhang, Feifei, Qin, Shana, Xiao, Xiang, Hao, Peng, Xu, Yikai. 2019. Overexpression of LIMD2 promotes the progression of non-small cell lung cancer. In Oncology letters, 18, 2073-2081. doi:10.3892/ol.2019.10473. https://pubmed.ncbi.nlm.nih.gov/31423280/
6. Carmelo, Victor A O, Kadarmideen, Haja N. 2020. Genome Regulation and Gene Interaction Networks Inferred From Muscle Transcriptome Underlying Feed Efficiency in Pigs. In Frontiers in genetics, 11, 650. doi:10.3389/fgene.2020.00650. https://pubmed.ncbi.nlm.nih.gov/32655625/
7. Wang, Fei, Li, Zhaoguo, Xu, Lei, Wang, Yue, Liu, Dazhong. 2018. LIMD2 targeted by miR‑34a promotes the proliferation and invasion of non‑small cell lung cancer cells. In Molecular medicine reports, 18, 4760-4766. doi:10.3892/mmr.2018.9464. https://pubmed.ncbi.nlm.nih.gov/30221696/
智鼠故事 
